These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Respiratory syncytial virus: different criteria for palivizumab use in different areas? Mitchell I South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741 [No Abstract] [Full Text] [Related]
4. Antibodies for the prevention and treatment of viral diseases. Sawyer LA Antiviral Res; 2000 Aug; 47(2):57-77. PubMed ID: 10996394 [TBL] [Abstract][Full Text] [Related]
5. Prevention of respiratory syncytial virus infection with palivizumab. Thomas M; Bedford-Russell A; Sharland M Monaldi Arch Chest Dis; 2000 Aug; 55(4):333-8. PubMed ID: 11057088 [TBL] [Abstract][Full Text] [Related]
6. [Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia]. Aliamovskaia GA; Keshinian ES Vestn Ross Akad Med Nauk; 2012; (12):30, 32-4. PubMed ID: 23530423 [TBL] [Abstract][Full Text] [Related]
7. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Zhu Z; Dimitrov AS; Chakraborti S; Dimitrova D; Xiao X; Broder CC; Dimitrov DS Expert Rev Anti Infect Ther; 2006 Feb; 4(1):57-66. PubMed ID: 16441209 [TBL] [Abstract][Full Text] [Related]
8. Trends in the development and approval of monoclonal antibodies for viral infections. Reichert JM BioDrugs; 2007; 21(1):1-7. PubMed ID: 17263584 [TBL] [Abstract][Full Text] [Related]
9. New strategies for control of respiratory syncytial virus infection. Nokes JD; Cane PA Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532 [TBL] [Abstract][Full Text] [Related]
18. [Respiratory syncytial immunoprophylaxis with palivizumab]. De Halleux V; Lombet J; Rigo J Rev Med Liege; 2007; 62(5-6):299-302. PubMed ID: 17725198 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against viruses and bacteria: a survey of patents. Xiao X; Dimitrov DS Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):171-7. PubMed ID: 18221173 [TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey. Oncel MY; Mutlu B; Kavurt S; Baş AY; Demirel N; Akyol M; Erdeve O; Dilmen U Turk J Pediatr; 2012; 54(4):344-51. PubMed ID: 23692714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]